Selected research
Market Structure
Global Iclusig Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Iclusig market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Iclusig is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Iclusig is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Iclusig is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Iclusig is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Iclusig include ARIAD Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Iclusig market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Iclusig and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Iclusig sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iclusig market size, projected growth trends, production technologies, key applications, and end-use industries.
Iclusig Segment by Company
ARIAD Pharmaceuticals
Iclusig Segment by Type
45mg
15mg
Iclusig Segment by Application
CML
ALL
Iclusig Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iclusig market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Iclusig and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iclusig.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Iclusig market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iclusig manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Iclusig in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Iclusig in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 45mg
- 15mg
Applications
- CML
- ALL
Companies covered
- ARIAD Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Iclusig Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Iclusig Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Iclusig Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Iclusig Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Iclusig Market Dynamics
- 2.1 Iclusig Industry Trends
- 2.2 Iclusig Industry Drivers
- 2.3 Iclusig Industry Opportunities and Challenges
- 2.4 Iclusig Industry Restraints
3 Iclusig Market by Manufacturers
- 3.1 Global Iclusig Revenue by Manufacturers (2021-2026)
- 3.2 Global Iclusig Sales by Manufacturers (2021-2026)
- 3.3 Global Iclusig Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Iclusig Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Iclusig Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Iclusig Manufacturers, Product Type & Application
- 3.7 Global Iclusig Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Iclusig Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Iclusig Players Market Share by Revenue in 2025
- 3.8.3 2025 Iclusig Tier 1, Tier 2, and Tier 3
4 Iclusig Market by Type
- 4.1 Iclusig Type Introduction
- 4.1.1 45mg
- 4.1.2 15mg
- 4.2 Global Iclusig Sales by Type
- 4.2.1 Global Iclusig Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Iclusig Sales by Type (2021-2032)
- 4.2.3 Global Iclusig Sales Market Share by Type (2021-2032)
- 4.3 Global Iclusig Revenue by Type
- 4.3.1 Global Iclusig Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Iclusig Revenue by Type (2021-2032)
- 4.3.3 Global Iclusig Revenue Market Share by Type (2021-2032)
5 Iclusig Market by Application
- 5.1 Iclusig Application Introduction
- 5.1.1 CML
- 5.1.2 ALL
- 5.2 Global Iclusig Sales by Application
- 5.2.1 Global Iclusig Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Iclusig Sales by Application (2021-2032)
- 5.2.3 Global Iclusig Sales Market Share by Application (2021-2032)
- 5.3 Global Iclusig Revenue by Application
- 5.3.1 Global Iclusig Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Iclusig Revenue by Application (2021-2032)
- 5.3.3 Global Iclusig Revenue Market Share by Application (2021-2032)
6 Global Iclusig Sales by Region
- 6.1 Global Iclusig Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Iclusig Sales by Region (2021-2032)
- 6.2.1 Global Iclusig Sales by Region (2021-2026)
- 6.2.2 Global Iclusig Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Iclusig Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Iclusig Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Iclusig Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Iclusig Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Iclusig Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Iclusig Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Iclusig Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Iclusig Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Iclusig Revenue by Region
- 7.1 Global Iclusig Revenue by Region
- 7.1.1 Global Iclusig Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Iclusig Revenue by Region (2021-2026)
- 7.1.3 Global Iclusig Revenue by Region (2027-2032)
- 7.1.4 Global Iclusig Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Iclusig Revenue (2021-2032)
- 7.2.2 North America Iclusig Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Iclusig Revenue (2021-2032)
- 7.3.2 Europe Iclusig Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Iclusig Revenue (2021-2032)
- 7.4.2 Asia-Pacific Iclusig Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Iclusig Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Iclusig Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 ARIAD Pharmaceuticals
- 8.1.1 ARIAD Pharmaceuticals Company Information
- 8.1.2 ARIAD Pharmaceuticals Business Overview
- 8.1.3 ARIAD Pharmaceuticals Iclusig Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 ARIAD Pharmaceuticals Iclusig Product Portfolio
- 8.1.5 ARIAD Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Iclusig Value Chain Analysis
- 9.1.1 Iclusig Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Iclusig Production Mode & Process
- 9.2 Iclusig Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Iclusig Distributors
- 9.2.3 Iclusig Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst